Download presentation
Presentation is loading. Please wait.
Published byTyrone Glenn Modified over 6 years ago
1
Renal Artery Stenosis: When to Revascularize in 2017
Jose D. Tafur, MD, Christopher J. White, MD Current Problems in Cardiology Volume 42, Issue 4, Pages (April 2017) DOI: /j.cpcardiol Copyright © 2017 Elsevier Inc. Terms and Conditions
2
FIG. 1 Improvement in cardiac destabilization syndromes after renal artery revascularization. (Reproduced with permission from Khosla et al18). (Color version of the figure available online.) Current Problems in Cardiology , DOI: ( /j.cpcardiol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
3
FIG. 2 Summary of initial reported series in terms of improvement of (A) hypertension and (B) renal function after renal artery revascularization. Despite a technical success of >95%, clinical outcomes did not match technical success. This suggests that selection of patients is crucial in order to obtain clinical benefit. (Color version of the figure available online.) Current Problems in Cardiology , DOI: ( /j.cpcardiol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
4
FIG. 3 Correlation between angiographic diameter stenosis and resting pressure gradient (BPG), hyperemic pressure gradient (HPG) and renal fractional flow reserve (FFR). (Reproduced with permission from Subramanian et al42). Current Problems in Cardiology , DOI: ( /j.cpcardiol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
5
FIG. 4 Correlation between fractional flow reserve (FFR) and resting pressure gradient (BPG) (top) and hyperemic pressure gradient (HPG) (bottom). (Reproduced with permission from Subramanian et al42) Current Problems in Cardiology , DOI: ( /j.cpcardiol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
6
FIG. 5 Blood pressure improvement at follow-up stratified by baseline renal FFR (<0.8 vs ≥0.80). (Reproduced with permission from Mitchell et al52). (Color version of the figure available online.) Current Problems in Cardiology , DOI: ( /j.cpcardiol ) Copyright © 2017 Elsevier Inc. Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.